TradeStation

Card image cap
Does Cobenfy Have the Potential to Become a Top Drug for BMY?

BMY's Cobenfy gains traction with $155M in 2025 sales, outpacing peers and showing strong uptake as Bristol Myers eyes new indications and growth....

Zacks Investment Research - 4/9/2026 1:16:13 PM More News for BMY
Stock Analysis for BMY

Related Stocks:

Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts

In the most recent trading session, Bristol Myers Squibb (BMY) closed at $59.2, indicating a +2.65% shift from the previous trading day....

Zacks Investment Research - 4/8/2026 6:46:30 PM More News for BMY
Stock Analysis for BMY

Related Stocks:

Card image cap
Settings
Color Scheme

Left Sidebar